# Contact TB-500 Chemical: Editorial Inquiries

> Contact TB-500 Chemical for editorial inquiries and citation corrections. An independent research digest — not a clinic, not a vendor, no medical advice.

For editorial questions and citation corrections.

## Editorial inquiries

Use the form below to reach TB-500 Chemical about the editorial content of this site. We welcome citation corrections, pointers to newly published studies on thymosin beta-4 or the Ac-LKKTETQ fragment, and questions about how a particular finding is sourced. If you believe a number on this site is wrong or a study is mischaracterized, tell us which page and which entry, and we will check it against the reference.

What this form is not: it is not a route to medical advice, a prescription, a clinical consultation, or a product. TB-500 Chemical does not provide healthcare services, does not sell anything, and cannot advise on personal use of any substance. For medical questions, consult a qualified, licensed healthcare professional.

## What we cannot help with

We cannot recommend a dose, identify a supplier, or comment on the legality of any individual's situation. The [TB-500 legal status and 503A category](/legal-status) page sets out the present-tense regulatory standing from FDA's own record, and that is the extent of the regulatory information this project offers. Everything here is general information and editorial commentary, not medical or legal advice, and not an offer to sell or supply any substance.

---

A chromatic-split scope reading of the TB-500 record — the Ac-LKKTETQ fragment held on one channel and full-length thymosin beta-4 on the other so the two are never mistaken for one trace, the FDA 503A standing read before anything else, with no clinic behind the scope and nothing here dispensed or sold.